These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22050340)

  • 41. Recent approaches for targeted drug delivery in rheumatoid arthritis diagnosis and treatment.
    Pirmardvand Chegini S; Varshosaz J; Taymouri S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):502-514. PubMed ID: 29661045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene therapy for patients with rheumatoid arthritis.
    Bessis N; Boissier MC
    Joint Bone Spine; 2006 Mar; 73(2):169-76. PubMed ID: 16226478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Biologics and mycobacterial diseases].
    Tsuyuguchi K; Matsumoto T
    Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Gene transfer to treat rheumatoid arthritis].
    Kohsaka H
    Nihon Rinsho; 2005 Sep; 63(9):1661-5. PubMed ID: 16164227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene therapy: what have we accomplished and where do we go from here?
    Evans CH
    J Rheumatol Suppl; 2005 Jan; 72():17-20. PubMed ID: 15660458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic lentivirus-mediated delivery of short hairpin RNA targeting calcium release-activated calcium channel 3 as gene therapy for collagen-induced arthritis.
    Liu S; Kiyoi T; Takemasa E; Maeyama K
    J Immunol; 2015 Jan; 194(1):76-83. PubMed ID: 25422506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene therapy: twenty-first century medicine.
    Verma IM; Weitzman MD
    Annu Rev Biochem; 2005; 74():711-38. PubMed ID: 15952901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Designing novel therapeutic strategies for rheumatic diseases.
    Apparailly F; Gay S; Jorgensen C
    Trends Immunol; 2001 Oct; 22(10):537-9. PubMed ID: 11702719
    [No Abstract]   [Full Text] [Related]  

  • 49. Rationalized Insights on Causes of Rheumatoid Arthritis in the Elderly and Women: Special Emphasis on Treatment Strategies.
    Srivastava S; Patel S; Singh D; Singh MR
    Crit Rev Ther Drug Carrier Syst; 2017; 34(2):97-147. PubMed ID: 28605317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-CD20 antibody rituximab in the treatment of rheumatoid arthritis.
    Korhonen R; Moilanen E
    Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):13-21. PubMed ID: 19686542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Future strategies in hematopoietic stem cell transplantation for rheumatoid arthritis.
    Burt RK; Barr W; Oyama Y; Traynor A; Slavin S
    J Rheumatol Suppl; 2001 Oct; 64():42-8. PubMed ID: 11642504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene therapy for arthritis.
    Robbins PD; Evans CH; Chernajovsky Y
    Gene Ther; 2003 May; 10(10):902-11. PubMed ID: 12732875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gene therapy for the treatment of cancer.
    Buchsbaum DJ; Curiel DT
    Cancer Biother Radiopharm; 2001 Aug; 16(4):275-88. PubMed ID: 11602998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Getting arthritis gene therapy into the clinic.
    Evans CH; Ghivizzani SC; Robbins PD
    Nat Rev Rheumatol; 2011 Apr; 7(4):244-9. PubMed ID: 21135882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Utilization of nanoparticle technology in rheumatoid arthritis treatment.
    Dolati S; Sadreddini S; Rostamzadeh D; Ahmadi M; Jadidi-Niaragh F; Yousefi M
    Biomed Pharmacother; 2016 May; 80():30-41. PubMed ID: 27133037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amelioration of arthritis by intraarticular dominant negative Ikk beta gene therapy using adeno-associated virus type 5.
    Tas SW; Adriaansen J; Hajji N; Bakker AC; Firestein GS; Vervoordeldonk MJ; Tak PP
    Hum Gene Ther; 2006 Aug; 17(8):821-32. PubMed ID: 16942442
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene therapy of rheumatoid arthritis via cytokine regulation: future perspectives.
    Chernajovsky Y; Feldmann M; Maini RN
    Br Med Bull; 1995 Apr; 51(2):503-16. PubMed ID: 7552079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell-Based Therapy and Genome Editing as Emerging Therapeutic Approaches to Treat Rheumatoid Arthritis.
    Chasov V; Ganeeva I; Zmievskaya E; Davletshin D; Gilyazova E; Valiullina A; Bulatov E
    Cells; 2024 Jul; 13(15):. PubMed ID: 39120313
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synoviocyte infection with adeno-associated virus (AAV) is neutralized by human synovial fluid from arthritis patients and depends on AAV serotype.
    Boissier MC; Lemeiter D; Clavel C; Valvason C; Laroche L; Begue T; Bessis N
    Hum Gene Ther; 2007 Jun; 18(6):525-35. PubMed ID: 17532727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene transfer to human rheumatoid synovial tissue engrafted in SCID mice.
    Jorgensen C; Demoly P; Noel D; Mathieu M; Piechaczyc M; Gougat C; Bousquet J; Sany J
    J Rheumatol; 1997 Nov; 24(11):2076-9. PubMed ID: 9375863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.